Annual Financial Report and Notice of AGM
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your TCF notes
Alderley Park, UK - 21 June 2024: TheraCryf plc (AIM: TCF), the clinical stage drug development company focussing on oncology and neuropsychiatry, announces that its Annual Report and Accounts for the year ended 31 March 2024 have been posted to shareholders and are now available on the Company website.
Additionally, the Company's AGM will take place on at 2.30 p.m. on Thursday 18 July 2024 in the Block 11 Lecture Theatre, Alderley Park Conference Centre, Cheshire, United Kingdom, SK10 4TG.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.